NPI: 1528016995 · NEBRASKA CITY, NE 68410 · Ambulatory Surgical Clinic/Center · NPI assigned 05/05/2006
Authorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
| Authorized Official | KUIPER, EVERT (CEO - CHI HEALTH) |
| NPI Enumeration Date | 05/05/2006 |
Other providers sharing the same authorized official: KUIPER, EVERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,255 | $331K |
| 2019 | 5,009 | $338K |
| 2020 | 5,592 | $303K |
| 2021 | 13,026 | $652K |
| 2022 | 12,317 | $591K |
| 2023 | 3,454 | $227K |
| 2024 | 1,293 | $115K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,445 | 3,152 | $772K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 1,657 | 1,466 | $517K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 340 | 279 | $127K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6,215 | 5,372 | $120K |
| 80053 | Comprehensive metabolic panel | 4,115 | 3,612 | $103K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1,014 | 976 | $69K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 504 | 472 | $67K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 643 | 554 | $64K |
| 80050 | General health panel | 882 | 791 | $52K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 313 | 280 | $40K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 224 | 214 | $35K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 698 | 526 | $35K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 844 | 265 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 333 | 289 | $28K |
| 36415 | Collection of venous blood by venipuncture | 2,541 | 2,105 | $27K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 209 | 189 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,215 | 1,171 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 759 | 402 | $23K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 425 | 158 | $22K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 549 | 206 | $22K |
| 80061 | Lipid panel | 1,432 | 1,385 | $21K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,059 | 904 | $19K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 213 | 181 | $19K |
| 71045 | Radiologic examination, chest; single view | 285 | 235 | $18K |
| 87660 | 459 | 408 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 643 | 631 | $16K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 694 | 599 | $16K |
| 81001 | 1,965 | 1,723 | $15K | |
| 87480 | 453 | 406 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 835 | 744 | $14K |
| 87510 | 439 | 393 | $14K | |
| 71046 | Radiologic examination, chest; 2 views | 313 | 272 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 354 | 325 | $13K |
| J3490 | Unclassified drugs | 2,560 | 1,017 | $12K |
| 87420 | 29 | 26 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 810 | 779 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,178 | 1,134 | $12K |
| 87081 | 709 | 694 | $11K | |
| 86710 | 172 | 90 | $10K | |
| 84484 | 170 | 128 | $9K | |
| 81025 | 620 | 590 | $9K | |
| 83880 | 108 | 93 | $5K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 641 | 488 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | 65 | 53 | $5K |
| 87631 | 32 | 31 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 58 | 49 | $4K |
| 81003 | 535 | 488 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 46 | 39 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 50 | 48 | $3K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 13 | 12 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 254 | 222 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 68 | 68 | $3K |
| 83690 | 83 | 75 | $2K | |
| 83605 | 116 | 86 | $2K | |
| 85018 | 265 | 261 | $1K | |
| 87807 | 19 | 19 | $1K | |
| 83655 | 47 | 42 | $1K | |
| 84439 | 93 | 91 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 42 | 38 | $1K |
| 87077 | 25 | 24 | $741.12 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13 | 12 | $375.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 32 | 26 | $366.44 |
| 86803 | 16 | 16 | $354.60 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 970 | 353 | $245.90 |
| J2704 | Injection, propofol, 10 mg | 23 | 12 | $107.22 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15 | 14 | $84.02 |